Burcon Closes Second Tranche of Non-Brokered Private Placement of Convertible Debentures of up to $6.9 Million

Core Viewpoint - Burcon NutraScience Corporation has successfully closed the second tranche of its non-brokered private placement of convertible debentures, raising a total of $6.9 million, which strengthens its balance sheet and supports its production scaling and commercial execution efforts [1][3]. Group 1: Private Placement Details - The second tranche of the private placement involved the issuance of convertible debentures totaling $2.75 million, contributing to an aggregate of $4 million raised from the first and second tranches [2]. - The first tranche closed on December 31, 2025, for $1.25 million, while the final tranche of $2.90 million is expected to close prior to April 24, 2026, as a non-cash loan conversion [4]. - Insiders have subscribed to a total of $2.7 million in convertible debentures across both tranches, indicating strong insider confidence in the company [2][5]. Group 2: Company Strategy and Future Outlook - The CEO of Burcon highlighted that the successful financing marks a significant milestone, enhancing the company's ability to scale production and accelerate commercial execution [3]. - The company is committed to building long-term value and aligning stakeholders through the remaining non-cash loan conversion component of the financing [3]. - Burcon is recognized as a leader in plant-based protein innovation, with a focus on sustainability and creating high-performance protein solutions for the food and beverage industry [7].